Thursday, May 02, 2024
Outlook.com
Outlook India
Outlook Business

Us Law Firm

The company is laying the groundwork for its global expansion through partnerships and strategic alliances for its flagship product, Eyecyte-RPE, an experimental treatment for Dry Age-Related Macular Degeneration